Voyager Therapeut (VYGR)

$2.97 +0.03 (1.02%)
Market Cap 166.01M
Revenue (ttm) 80.00M
Net Income (ttm) -65.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -81.25%
Debt to Equity Ratio 0.00
Volume 667,500
Avg Vol 550,112
Day's Range N/A - N/A
Shares Out 55.34M
Stochastic %K 14%
Beta 0.82
Analysts Strong Sell
Price Target $15.19

Company Profile

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. The company's lead product candidate is VY7523, an anti-tau antibody program for the treatment of alzheimer's disease (AD). Its product pipeline includes VY1706, a tau silencing gene therapy in preclinical trial for the treatment of alzheimer's disease; SOD1 silencing gene therapy program for treating amyotrophic lateral sclerosis in preclinical trial; and vectorized anti-amy...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 259 5340
Address:
75 Hayden Avenue, Lexington, United States
pickens1
pickens1 Jun. 26 at 6:51 PM
$VYGR She is on sale...
0 · Reply
360sage
360sage Jun. 26 at 6:34 PM
$VYGR Building a position
0 · Reply
BigDaddyPumper
BigDaddyPumper Jun. 25 at 2:43 AM
$VYGR Still adding. Volume precedes price
0 · Reply
amda
amda Jun. 24 at 6:41 PM
$VYGR wow: Average Price TargetPrice Target 30.00 Average Price Target 16.00 Upside (428.93%) Lowest Price Target 9.00 $SPY $LLY $MRNA $GME
0 · Reply
gforce77
gforce77 Jun. 23 at 2:39 PM
$VYGR taking a position here seems too cheap to me. Like this long term.
0 · Reply
amda
amda Jun. 20 at 3:12 PM
$VYGR new position: in at 2.97
0 · Reply
RunnerSignals
RunnerSignals Jun. 14 at 5:06 PM
Breakout Watch $ORCL $SOFI $PLG $NVO $VYGR are showing serious momentum. Big volume, strong trends. are they still a buy or running out of steam? stocksrunner.com/articles/2025-06-14-top-momentum-stocks-breaking-out
0 · Reply
Dirt_Nasty_Trades
Dirt_Nasty_Trades Jun. 12 at 2:14 PM
$VYGR long and strong!
0 · Reply
Dirt_Nasty_Trades
Dirt_Nasty_Trades Jun. 11 at 2:51 PM
$VOYG Get ready!! $VYGR already starting to run off the ipo like the $CRCL Ipo 👇
1 · Reply
Laklak06
Laklak06 Jun. 11 at 2:37 PM
$VYGR
0 · Reply
Latest News on VYGR
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Jun 10, 2025, 7:00 AM EDT - 16 days ago

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication

May 15, 2025, 7:00 AM EDT - 6 weeks ago

Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication

Voyager Reports First Quarter 2025 Financial and Operating Results

May 6, 2025, 4:01 PM EDT - 7 weeks ago

Voyager Reports First Quarter 2025 Financial and Operating Results

Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting

Apr 28, 2025, 4:30 PM EDT - 2 months ago

Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting

Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025

Mar 31, 2025, 7:00 AM EDT - 3 months ago

Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025

Voyager Therapeutics, Inc. (VYGR) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 7:35 PM EDT - 3 months ago

Voyager Therapeutics, Inc. (VYGR) Q4 2024 Earnings Call Transcript

Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 11, 2025, 4:01 PM EDT - 3 months ago

Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast

Mar 4, 2025, 7:00 AM EST - 4 months ago

Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast

Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer's Disease

Mar 3, 2025, 7:00 AM EST - 4 months ago

Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer's Disease

The Schall Law Firm Invites Shareholders With Losses In Voyager Therapeutics, Inc. To Join A Securities Fraud Investigation

Mar 2, 2025, 11:00 AM EST - 4 months ago

The Schall Law Firm Invites Shareholders With Losses In Voyager Therapeutics, Inc. To Join A Securities Fraud Investigation

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

Feb 25, 2025, 7:00 AM EST - 4 months ago

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

VYGR Investors Have Opportunity to Join Voyager Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

Feb 21, 2025, 10:51 PM EST - 4 months ago

VYGR Investors Have Opportunity to Join Voyager Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

Voyager Provides Update on SOD1 ALS Gene Therapy Program

Feb 11, 2025, 7:00 AM EST - 4 months ago

Voyager Provides Update on SOD1 ALS Gene Therapy Program

Voyager: Crossing The Blood-Brain Barrier, Competitors, And Investment Relevance

Jan 30, 2025, 5:06 PM EST - 5 months ago

Voyager: Crossing The Blood-Brain Barrier, Competitors, And Investment Relevance

Voyager Therapeutics, Inc. (VYGR) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 11:07 PM EST - 8 months ago

Voyager Therapeutics, Inc. (VYGR) Q3 2024 Earnings Call Transcript

Voyager Reports Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 4:01 PM EST - 8 months ago

Voyager Reports Third Quarter 2024 Financial and Operating Results

Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast

Nov 5, 2024, 7:00 AM EST - 8 months ago

Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 29, 2024, 4:01 PM EDT - 10 months ago

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Voyager: Anti-Tau Antibody Differentiation For AD Treatment Could Boost Prospects

Aug 26, 2024, 3:24 PM EDT - 10 months ago

Voyager: Anti-Tau Antibody Differentiation For AD Treatment Could Boost Prospects

Voyager Therapeutics, Inc. (VYGR) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 5:43 AM EDT - 11 months ago

Voyager Therapeutics, Inc. (VYGR) Q2 2024 Earnings Call Transcript

Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

Aug 7, 2024, 7:00 AM EDT - 11 months ago

Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results

Aug 6, 2024, 4:01 PM EDT - 11 months ago

Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results

Voyager Therapeutics to Present at Multiple Virtual Investor Conferences

Jun 13, 2024, 4:01 PM EDT - 1 year ago

Voyager Therapeutics to Present at Multiple Virtual Investor Conferences

Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer

Jun 13, 2024, 7:00 AM EDT - 1 year ago

Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer

The 'Undercovered' Dozen From June 1-6

Jun 7, 2024, 6:26 PM EDT - 1 year ago

The 'Undercovered' Dozen From June 1-6

ALNY CLOV CRSP ENVX GAM HAL LPA

Voyager: Alzheimer's Clinical Trial Start (VY-TAU01) Strengthens Investment Thesis

Jun 5, 2024, 11:52 AM EDT - 1 year ago

Voyager: Alzheimer's Clinical Trial Start (VY-TAU01) Strengthens Investment Thesis

3 Biotech Names Under $10 I Own

Jun 2, 2024, 10:18 AM EDT - 1 year ago

3 Biotech Names Under $10 I Own

AUPH FOLD

Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer's Disease

May 16, 2024, 7:00 AM EDT - 1 year ago

Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer's Disease

Voyager Therapeutics, Inc. (VYGR) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:43 AM EDT - 1 year ago

Voyager Therapeutics, Inc. (VYGR) Q1 2024 Earnings Call Transcript

Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results

May 13, 2024, 4:01 PM EDT - 1 year ago

Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results

Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting

May 8, 2024, 6:00 AM EDT - 1 year ago

Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting

Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast

May 6, 2024, 7:00 AM EDT - 1 year ago

Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast

Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting

Apr 22, 2024, 4:30 PM EDT - 1 year ago

Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting

Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment

Apr 16, 2024, 7:00 AM EDT - 1 year ago

Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment

Voyager Therapeutics: On Track To Deliver High Returns On Investment

Mar 13, 2024, 1:11 PM EDT - 1 year ago

Voyager Therapeutics: On Track To Deliver High Returns On Investment

pickens1
pickens1 Jun. 26 at 6:51 PM
$VYGR She is on sale...
0 · Reply
360sage
360sage Jun. 26 at 6:34 PM
$VYGR Building a position
0 · Reply
BigDaddyPumper
BigDaddyPumper Jun. 25 at 2:43 AM
$VYGR Still adding. Volume precedes price
0 · Reply
amda
amda Jun. 24 at 6:41 PM
$VYGR wow: Average Price TargetPrice Target 30.00 Average Price Target 16.00 Upside (428.93%) Lowest Price Target 9.00 $SPY $LLY $MRNA $GME
0 · Reply
gforce77
gforce77 Jun. 23 at 2:39 PM
$VYGR taking a position here seems too cheap to me. Like this long term.
0 · Reply
amda
amda Jun. 20 at 3:12 PM
$VYGR new position: in at 2.97
0 · Reply
RunnerSignals
RunnerSignals Jun. 14 at 5:06 PM
Breakout Watch $ORCL $SOFI $PLG $NVO $VYGR are showing serious momentum. Big volume, strong trends. are they still a buy or running out of steam? stocksrunner.com/articles/2025-06-14-top-momentum-stocks-breaking-out
0 · Reply
Dirt_Nasty_Trades
Dirt_Nasty_Trades Jun. 12 at 2:14 PM
$VYGR long and strong!
0 · Reply
Dirt_Nasty_Trades
Dirt_Nasty_Trades Jun. 11 at 2:51 PM
$VOYG Get ready!! $VYGR already starting to run off the ipo like the $CRCL Ipo 👇
1 · Reply
Laklak06
Laklak06 Jun. 11 at 2:37 PM
$VYGR
0 · Reply
patient_profits
patient_profits Jun. 11 at 2:34 PM
$VOYG $VYGR
0 · Reply
Dirt_Nasty_Trades
Dirt_Nasty_Trades Jun. 11 at 2:27 PM
$VYGR these shorts are in for pain today!!
0 · Reply
Dirt_Nasty_Trades
Dirt_Nasty_Trades Jun. 11 at 2:22 PM
$VOYG IPO $VYGR 👀👇 Already getting hits in before the crowd Just like circle ipo
0 · Reply
Dirt_Nasty_Trades
Dirt_Nasty_Trades Jun. 11 at 1:45 PM
$VOYG $VYGR Going to run off retail thinking its the new voyager ipo VOLUME
1 · Reply
Dirt_Nasty_Trades
Dirt_Nasty_Trades Jun. 11 at 1:30 PM
$VYGR going to run because retail traders going to think this is voyager ipo
0 · Reply
G101SPM
G101SPM Jun. 10 at 2:49 PM
$VYGR $3.42 ask. BUY/ADD 2X TO LONG POSITION carries SPM 83.96 tag to $10.00 in midterm. DAC (dollar average cost includes this BUY) (3 ) $4.59 .
0 · Reply
Laklak06
Laklak06 Jun. 10 at 2:32 PM
$VYGR
0 · Reply
rich54
rich54 Jun. 9 at 4:51 PM
$VYGR why is this junk selling off when every other biotech/small cap is running? $SGMO $XBI
1 · Reply
Stockboi_
Stockboi_ Jun. 9 at 2:47 PM
$VYGR good above 3.25
0 · Reply
Laklak06
Laklak06 Jun. 9 at 4:48 AM
$VYGR 5$
0 · Reply
Winning_calls
Winning_calls Jun. 9 at 3:45 AM
$VYGR pick me up @ $3.53
0 · Reply
StacksOnStocks
StacksOnStocks Jun. 9 at 3:13 AM
$VYGR hopefully we have a good week 🚀
0 · Reply